Cabaletta Bio, Inc.
US ˙ NasdaqGS ˙ US12674W1099

Introduction

This page provides a comprehensive analysis of the known insider trading history of Brian Daniels. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Brian Daniels has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CABA / Cabaletta Bio, Inc. Director 0
US:BMY / Bristol-Myers Squibb Company SVP Global Dev & Med Affairs 9,340
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Brian Daniels. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CABA / Cabaletta Bio, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CABA / Cabaletta Bio, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CABA / Cabaletta Bio, Inc. Insider Trades
Insider Sales CABA / Cabaletta Bio, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CABA / Cabaletta Bio, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CABA / Cabaletta Bio, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Brian Daniels as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-06-28 2021-06-01 4/A CABA Cabaletta Bio, Inc.
Stock Option (Right to buy)
A - Award -22,000 0 -100.00
2021-06-03 2021-06-01 4 CABA Cabaletta Bio, Inc.
Stock Option (Right to buy)
A - Award 22,000 22,000
2020-02-13 2020-02-11 4 CABA Cabaletta Bio, Inc.
Stock Option (Right to Buy)
A - Award 44,000 44,000
2014-07-02 2014-07-01 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -4,671 9,340 -33.34
2014-07-02 2014-07-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -2,103 94,374 -2.18 48.12 -101,196 4,541,279
2014-07-02 2014-07-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 4,671 96,477 5.09
2014-03-12 2014-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 6,741 6,741
2014-03-12 2014-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -2,528 7,587 -24.99
2014-03-12 2014-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,655 91,806 -1.77 56.14 -92,912 5,153,991
2014-03-12 2014-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 1,147 93,461 1.24
2014-03-12 2014-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 2,528 92,314 2.82
2014-03-10 2014-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -3,010 6,019 -33.34
2014-03-10 2014-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -2,276 89,786 -2.47 55.56 -126,455 4,988,512
2014-03-10 2014-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 2,044 92,062 2.27
2014-03-10 2014-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 3,010 90,018 3.46
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 160 5,295 3.12
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 5,135 5,135
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 425 14,062 3.12
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 6,112 13,637 81.22
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -40,119 0 -100.00
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 1,213 40,119 3.12
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 18,600 38,906 91.60
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -3,703 3,703 -50.00
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -3,813 0 -100.00
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -2,691 0 -100.00
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -16,402 87,008 -15.86 53.49 -877,343 4,654,060
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 40,119 103,410 63.39
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -3,335 63,291 -5.01 53.49 -178,389 3,385,438
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 3,703 66,626 5.88
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 3,703 62,923 6.25
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -3,434 59,220 -5.48 53.49 -183,685 3,167,680
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 3,813 62,654 6.48
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 3,813 58,841 6.93
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,212 55,028 -2.16 53.49 -64,830 2,943,450
2014-03-05 2014-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 2,691 56,240 5.03
2014-02-06 2014-02-06 4 BMY BRISTOL MYERS SQUIBB CO
Option (right to buy)
M - Exercise -18,750 0 -100.00
2014-02-06 2014-02-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -28,440 53,549 -34.69 48.93 -1,391,433 2,619,898
2014-02-06 2014-02-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 18,750 81,989 29.65 28.11 527,062 2,304,712
2013-05-08 2013-05-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -15,000 63,239 -19.17 39.93 -598,950 2,525,135
2013-03-11 2013-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 10,115 10,115
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 289 7,525 3.99
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 7,236 7,236
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 779 20,306 3.99
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 8,808 19,527 82.17
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -31,546 0 -100.00
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 1,209 31,546 3.98
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 9,168 30,337 43.31
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -3,009 9,029 -25.00
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -3,812 11,219 -25.36
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -3,703 15,031 -19.77
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -15,247 78,239 -16.31 37.53 -572,220 2,936,311
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -2,122 93,486 -2.22 37.53 -79,639 3,508,531
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,987 95,608 -2.04 37.53 -74,572 3,588,170
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,276 97,595 -1.29 37.53 -47,888 3,662,742
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 416 98,871 0.42
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 1,630 98,455 1.68
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 1,883 96,825 1.98
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 3,009 94,942 3.27
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 3,703 91,933 4.20
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 3,812 88,230 4.52
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 31,546 84,418 59.66
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -1,870 0 -100.00
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -697 52,872 -1.30 36.94 -25,747 1,953,093
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 1,870 53,569 3.62
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -2,691 2,691 -50.00
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,002 51,699 -1.90 37.15 -37,224 1,920,619
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 2,691 52,701 5.38
2013-01-31 2013-01-31 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -12,000 50,010 -19.35 36.22 -434,640 1,811,364
2012-08-14 2012-08-10 4 BMY BRISTOL MYERS SQUIBB CO
Option (right to buy)
M - Exercise -5,989 0 -100.00
2012-08-14 2012-08-10 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -71,556 23,852 -75.00
2012-08-14 2012-08-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -79,900 62,010 -56.30 31.72 -2,534,428 1,966,957
2012-08-14 2012-08-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 5,989 141,910 4.41 23.14 138,585 3,283,797
2012-08-14 2012-08-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 71,556 135,921 111.17 17.51 1,252,946 2,379,977
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 461 10,719 4.49
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 10,258 10,258
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -28,073 21,169 -57.01
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 910 49,242 1.88
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 10,010 48,332 26.12
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 10,678 38,322 38.63
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 12,038 12,038
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -11,375 64,365 -15.02 32.33 -367,754 2,080,920
2012-03-09 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 28,073 75,740 58.89
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -1,870 1,870 -50.00
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -680 47,667 -1.41 32.59 -22,161 1,553,468
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 1,870 48,347 4.02
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -2,691 5,382 -33.33
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -979 46,477 -2.06 32.59 -31,906 1,514,685
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 2,691 47,456 6.01
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -3,813 18,734 -16.91
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,831 44,765 -3.93 32.59 -59,672 1,458,891
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 1,222 46,596 2.69
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 3,813 45,374 9.17
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -3,702 22,547 -14.10
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,711 41,561 -3.95 32.64 -55,847 1,356,551
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 1,003 43,272 2.37
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 3,702 42,269 9.60
2011-12-29 2010-03-06 4/A BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -2,366 2,367 -49.99
2008-03-06 2008-03-04 4 (BMY) BRISTOL MYERS SQUIBB CO
Restricted Stock Units
A - Award 5,610 5,610
2008-03-06 2008-03-04 4 (BMY) BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
A - Award 73,477 73,477
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)